Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Finasteride changes hormone levels and certain proteins in rats, but these effects can be reversed after stopping the drug.

Ageratum conyzoides extract promotes hair growth and regrowth.

Finasteride temporarily suppresses brain activity, but some effects last even after stopping.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.

The seed extract of Lepidium sativum L. can potentially treat hair loss, showing effects similar to 5% minoxidil.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

High TNF-α levels may increase hair loss risk after PRP therapy.

A new method quickly extracts and identifies proteins from hair and other keratin sources.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Formalin-induced pain increases testosterone breakdown in the rat brain and spinal cord.

Dutasteride reduces DHT more effectively than finasteride.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Finasteride effectively inhibits 5α reductase, while plant extracts like Permixon and Bazoton don't show significant results.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Finasteride may cause kidney damage.